PSNC sets up Community Pharmacy Brexit Forum

PSNC sets up Community Pharmacy Brexit Forum

July 27 2018 Chief executives of representative bodies involved in community pharmacy and the...

Boots and PDA discuss union recognition, but no agreement as yet

Boots and PDA discuss union recognition, but no agreement as yet

July 26 2018 The Pharmacists’ Defence Association has been holding talks with members of...

Appeal process for overpayment recovery by NHS England to start in August

Appeal process for overpayment recovery by NHS England to start in August

July 26 2018 New regulations introducing an appeals process to challenge NHS England recovering...

MPs hear about community pharmacy role in LTC management

MPs hear about community pharmacy role in LTC management

July 20 2018 Community pharmacy representatives have briefed MPs about the role pharmacy teams...

MHRA launches consultation on implementing FMD safety features

MHRA launches consultation on implementing FMD safety features

July 20 2018 A consultation asking for views on how the safety features required under the...

  • PSNC sets up Community Pharmacy Brexit Forum

    PSNC sets up Community Pharmacy Brexit Forum

    Friday, 27 July 2018 16:04
  • Boots and PDA discuss union recognition, but no agreement as yet

    Boots and PDA discuss union recognition, but no agreement as yet

    Thursday, 26 July 2018 15:19
  • Appeal process for overpayment recovery by NHS England to start in August

    Appeal process for overpayment recovery by NHS England to start in August

    Thursday, 26 July 2018 15:04
  • MPs hear about community pharmacy role in LTC management

    MPs hear about community pharmacy role in LTC management

    Friday, 20 July 2018 16:30
  • MHRA launches consultation on implementing FMD safety features

    MHRA launches consultation on implementing FMD safety features

    Friday, 20 July 2018 14:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a psoriasis image cbAugust 22 2017

Dovonex Psoriasis 50microgram/g Ointment is to be made available as an over the counter medicine. 

 The MHRA announced that the ointment, containing calcipotriol will be available in 60g tubes for adults with mild to moderate plaque psoriasis which has been previously diagnosed by a doctor.

The packaging will be specially designed, as part of the licensing requirement for the Pharmacy medicine version of Dovonex, the MHRA said. “Pharmacists and their staff will be able to provide suitable advice to the patient to ensure that the product is suitable for them. The outer packaging and the patient information leaflet also include an image of plaque psoriasis which will help both pharmacists and patients in this respect.”

An estimated 2% of the population have psoriasis. The MHRA issued its consultation on the POM to P switch in March. It has now published the responses it received to the consultation, when announcing that market authorisation had been approved.

Dr Sarah Branch, MHRA’s Deputy Director of VRMM, said: “Psoriasis is a chronic disease which can have a major impact on people’s quality of life. By making this medicine more widely available, patients will be able to treat flare ups quickly without the need for a prescription.

Royal Pharmaceutical Society President Ash Soni added: “Pharmacists are already able to sell products for the treatment of psoriasis with appropriate advice on management, application and side effects. We welcome the addition of Dovonex Psoriasis Ointment to the range of products available.

“Pharmacists are more easily accessible than doctors and trained to give advice on medicine use, make sure the chosen medicine is appropriate and check if a person needs to see another health professional. This is an important patient benefit and we would like to see more medicine available through pharmacy in future.”

Links:
MHRA announcement   
Dovonex Consultation and responses      

Business News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...